nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.57	1	CrCtD
Tripelennamine—Rosiglitazone—Pioglitazone—type 2 diabetes mellitus	0.234	0.696	CrCrCtD
Tripelennamine—Mepyramine—Rosiglitazone—type 2 diabetes mellitus	0.0539	0.16	CrCrCtD
Tripelennamine—Chloropyramine—Rosiglitazone—type 2 diabetes mellitus	0.0484	0.144	CrCrCtD
Tripelennamine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.025	0.293	CbGbCtD
Tripelennamine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0231	0.271	CbGbCtD
Tripelennamine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.019	0.222	CbGbCtD
Tripelennamine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0182	0.213	CbGbCtD
Tripelennamine—Bepridil—KCNQ1—type 2 diabetes mellitus	0.000306	0.126	CrCbGaD
Tripelennamine—Aprindine—CALM1—type 2 diabetes mellitus	0.000236	0.0971	CrCbGaD
Tripelennamine—Bepridil—CALM1—type 2 diabetes mellitus	0.000146	0.06	CrCbGaD
Tripelennamine—Captodiame—HTR2C—type 2 diabetes mellitus	0.00013	0.0534	CrCbGaD
Tripelennamine—Rosiglitazone—PPARG—type 2 diabetes mellitus	0.000127	0.0522	CrCbGaD
Tripelennamine—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000113	0.0467	CrCbGaD
Tripelennamine—Rosiglitazone—CYP1A2—type 2 diabetes mellitus	8.26e-05	0.034	CrCbGaD
Tripelennamine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	6.3e-05	0.026	CrCbGaD
Tripelennamine—Carbinoxamine—CYP2E1—type 2 diabetes mellitus	5.45e-05	0.0225	CrCbGaD
Tripelennamine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	5.37e-05	0.0221	CrCbGaD
Tripelennamine—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	5.14e-05	0.0212	CrCbGaD
Tripelennamine—Rosiglitazone—ALB—type 2 diabetes mellitus	4.77e-05	0.0196	CrCbGaD
Tripelennamine—Brompheniramine—CYP2E1—type 2 diabetes mellitus	4.72e-05	0.0194	CrCbGaD
Tripelennamine—Tamoxifen—ABCC2—type 2 diabetes mellitus	4.36e-05	0.018	CrCbGaD
Tripelennamine—Doxepin—ADRA2A—type 2 diabetes mellitus	4.18e-05	0.0172	CrCbGaD
Tripelennamine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	4.17e-05	0.0172	CrCbGaD
Tripelennamine—Disopyramide—CYP3A4—type 2 diabetes mellitus	4e-05	0.0165	CrCbGaD
Tripelennamine—Doxepin—HTR2C—type 2 diabetes mellitus	3.85e-05	0.0159	CrCbGaD
Tripelennamine—Promazine—ADRA2A—type 2 diabetes mellitus	3.71e-05	0.0153	CrCbGaD
Tripelennamine—Carbinoxamine—CYP3A4—type 2 diabetes mellitus	3.43e-05	0.0141	CrCbGaD
Tripelennamine—Promazine—HTR2C—type 2 diabetes mellitus	3.42e-05	0.0141	CrCbGaD
Tripelennamine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	3.23e-05	0.0133	CrCbGaD
Tripelennamine—Tamoxifen—CYP2E1—type 2 diabetes mellitus	3.06e-05	0.0126	CrCbGaD
Tripelennamine—Imipramine—HTR2C—type 2 diabetes mellitus	2.99e-05	0.0123	CrCbGaD
Tripelennamine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	2.99e-05	0.0123	CrCbGaD
Tripelennamine—Amitriptyline—HTR2C—type 2 diabetes mellitus	2.98e-05	0.0123	CrCbGaD
Tripelennamine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	2.97e-05	0.0123	CrCbGaD
Tripelennamine—Brompheniramine—CYP3A4—type 2 diabetes mellitus	2.97e-05	0.0122	CrCbGaD
Tripelennamine—Chlorphenamine—CYP3A4—type 2 diabetes mellitus	2.92e-05	0.012	CrCbGaD
Tripelennamine—Tamoxifen—CYP1A2—type 2 diabetes mellitus	2.91e-05	0.012	CrCbGaD
Tripelennamine—Doxepin—CYP1A2—type 2 diabetes mellitus	2.9e-05	0.012	CrCbGaD
Tripelennamine—Methadone—CYP1A2—type 2 diabetes mellitus	2.89e-05	0.0119	CrCbGaD
Tripelennamine—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	2.82e-05	0.0116	CrCbGaD
Tripelennamine—Promazine—CYP1A2—type 2 diabetes mellitus	2.58e-05	0.0106	CrCbGaD
Tripelennamine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	2.47e-05	0.0102	CrCbGaD
Tripelennamine—Imipramine—CYP2E1—type 2 diabetes mellitus	2.37e-05	0.00978	CrCbGaD
Tripelennamine—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	2.36e-05	0.00973	CrCbGaD
Tripelennamine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	2.36e-05	0.00972	CrCbGaD
Tripelennamine—Imipramine—CYP1A2—type 2 diabetes mellitus	2.26e-05	0.00931	CrCbGaD
Tripelennamine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	2.25e-05	0.00925	CrCbGaD
Tripelennamine—Tamoxifen—CYP3A4—type 2 diabetes mellitus	1.93e-05	0.00794	CrCbGaD
Tripelennamine—Doxepin—CYP3A4—type 2 diabetes mellitus	1.92e-05	0.00792	CrCbGaD
Tripelennamine—Methadone—CYP3A4—type 2 diabetes mellitus	1.91e-05	0.00788	CrCbGaD
Tripelennamine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	1.87e-05	0.00772	CrCbGaD
Tripelennamine—Promazine—CYP3A4—type 2 diabetes mellitus	1.71e-05	0.00704	CrCbGaD
Tripelennamine—Imipramine—CYP3A4—type 2 diabetes mellitus	1.5e-05	0.00616	CrCbGaD
Tripelennamine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	1.49e-05	0.00612	CrCbGaD
Tripelennamine—Amitriptyline—ALB—type 2 diabetes mellitus	1.3e-05	0.00534	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	1.24e-05	0.00213	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	1.24e-05	0.00212	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	1.24e-05	0.00212	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	1.21e-05	0.00207	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	1.2e-05	0.00206	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	1.2e-05	0.00205	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	1.19e-05	0.00204	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	1.18e-05	0.00202	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	1.18e-05	0.00202	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	1.16e-05	0.00199	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	1.16e-05	0.00199	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	1.14e-05	0.00196	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	1.13e-05	0.00194	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GIP—type 2 diabetes mellitus	1.09e-05	0.00186	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.08e-05	0.00186	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GCG—type 2 diabetes mellitus	1.08e-05	0.00184	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.07e-05	0.00183	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	1.05e-05	0.0018	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	1.02e-05	0.00175	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	1.02e-05	0.00175	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	9.99e-06	0.00171	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	9.85e-06	0.00169	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	9.49e-06	0.00162	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	9.41e-06	0.00161	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	9.28e-06	0.00159	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	9.26e-06	0.00159	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	9.2e-06	0.00157	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	9.15e-06	0.00157	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	9.01e-06	0.00154	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	8.94e-06	0.00153	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	8.78e-06	0.0015	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	8.71e-06	0.00149	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	8.63e-06	0.00148	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	8.27e-06	0.00142	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	8.18e-06	0.0014	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	7.97e-06	0.00136	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	7.94e-06	0.00136	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	7.84e-06	0.00134	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	7.81e-06	0.00134	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	7.78e-06	0.00133	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	7.77e-06	0.00133	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	7.61e-06	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	7.59e-06	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	7.55e-06	0.00129	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	7.31e-06	0.00125	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	7.31e-06	0.00125	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	7.23e-06	0.00124	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	7.23e-06	0.00124	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	7.23e-06	0.00124	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	7.23e-06	0.00124	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	7.06e-06	0.00121	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	7.02e-06	0.0012	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	6.89e-06	0.00118	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	6.85e-06	0.00117	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	6.85e-06	0.00117	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	6.85e-06	0.00117	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	6.82e-06	0.00117	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	6.68e-06	0.00114	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	6.68e-06	0.00114	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	6.65e-06	0.00114	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	6.57e-06	0.00113	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	6.56e-06	0.00112	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	6.53e-06	0.00112	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	6.43e-06	0.0011	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	6.37e-06	0.00109	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	6.2e-06	0.00106	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	6.11e-06	0.00105	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	6.1e-06	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	6.08e-06	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	6.07e-06	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	6.04e-06	0.00103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	6.03e-06	0.00103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	6.03e-06	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	5.98e-06	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	5.97e-06	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	5.95e-06	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	5.84e-06	0.001	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	5.82e-06	0.000997	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.82e-06	0.000997	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	5.82e-06	0.000997	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	5.82e-06	0.000997	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	5.82e-06	0.000997	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	5.68e-06	0.000973	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	5.64e-06	0.000966	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	5.52e-06	0.000946	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	5.47e-06	0.000937	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	5.43e-06	0.000931	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	5.33e-06	0.000912	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	5.33e-06	0.000912	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	5.28e-06	0.000905	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	5.24e-06	0.000898	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	5.19e-06	0.000889	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	5.17e-06	0.000886	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	4.95e-06	0.000848	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	4.95e-06	0.000848	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	4.95e-06	0.000848	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	4.92e-06	0.000842	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	4.87e-06	0.000835	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	4.83e-06	0.000827	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	4.83e-06	0.000827	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	4.76e-06	0.000815	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	4.75e-06	0.000813	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	4.75e-06	0.000813	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	4.71e-06	0.000806	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	4.71e-06	0.000806	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	4.7e-06	0.000804	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	4.7e-06	0.000804	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	4.69e-06	0.000803	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	4.67e-06	0.0008	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	4.63e-06	0.000793	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	4.57e-06	0.000783	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	4.57e-06	0.000783	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	4.49e-06	0.000769	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	4.47e-06	0.000765	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	4.41e-06	0.000756	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	4.41e-06	0.000756	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	4.41e-06	0.000756	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	4.4e-06	0.000753	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	4.3e-06	0.000736	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	4.24e-06	0.000727	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	4.2e-06	0.000719	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	4.17e-06	0.000714	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	4.15e-06	0.000711	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	4.14e-06	0.00071	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	4.08e-06	0.000699	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.07e-06	0.000697	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.07e-06	0.000696	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.05e-06	0.000693	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.99e-06	0.000684	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	3.9e-06	0.000668	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	3.89e-06	0.000665	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.88e-06	0.000664	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.77e-06	0.000646	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.76e-06	0.000645	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.76e-06	0.000645	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	3.75e-06	0.000643	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	3.75e-06	0.000643	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	3.75e-06	0.000643	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	3.75e-06	0.000643	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.71e-06	0.000635	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.66e-06	0.000627	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.65e-06	0.000624	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.65e-06	0.000624	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	3.6e-06	0.000616	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.58e-06	0.000614	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.57e-06	0.000611	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.57e-06	0.000611	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.52e-06	0.000604	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.43e-06	0.000587	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	3.35e-06	0.000573	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.32e-06	0.000568	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.3e-06	0.000566	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	3.26e-06	0.000559	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.26e-06	0.000559	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.21e-06	0.00055	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.2e-06	0.000548	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	3.12e-06	0.000535	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	3.06e-06	0.000524	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	3.06e-06	0.000524	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.05e-06	0.000523	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	3e-06	0.000514	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3e-06	0.000514	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3e-06	0.000513	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.98e-06	0.000511	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.98e-06	0.000511	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.98e-06	0.000511	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.96e-06	0.000507	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.91e-06	0.000498	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.88e-06	0.000493	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.84e-06	0.000486	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.81e-06	0.000482	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.77e-06	0.000475	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.77e-06	0.000475	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.76e-06	0.000473	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.75e-06	0.000471	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.72e-06	0.000466	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.68e-06	0.000459	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.67e-06	0.000458	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.67e-06	0.000458	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.67e-06	0.000458	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.67e-06	0.000457	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.64e-06	0.000452	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.62e-06	0.000449	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.6e-06	0.000445	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.56e-06	0.000438	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.55e-06	0.000436	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.51e-06	0.000429	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2.45e-06	0.000419	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.42e-06	0.000414	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.42e-06	0.000414	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.4e-06	0.000411	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.36e-06	0.000404	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.36e-06	0.000404	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.32e-06	0.000397	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.32e-06	0.000397	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	2.31e-06	0.000395	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.2e-06	0.000377	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.19e-06	0.000376	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.19e-06	0.000375	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.15e-06	0.000369	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.15e-06	0.000368	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.15e-06	0.000368	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.12e-06	0.000363	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.02e-06	0.000347	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2e-06	0.000342	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2e-06	0.000342	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.99e-06	0.000341	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.96e-06	0.000336	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.91e-06	0.000328	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.91e-06	0.000326	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.85e-06	0.000317	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	1.83e-06	0.000314	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.82e-06	0.000312	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.8e-06	0.000309	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.78e-06	0.000305	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.78e-06	0.000304	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.77e-06	0.000304	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.77e-06	0.000304	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.76e-06	0.000302	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.73e-06	0.000296	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.71e-06	0.000292	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.68e-06	0.000288	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.64e-06	0.000281	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.61e-06	0.000275	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.61e-06	0.000275	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.61e-06	0.000275	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.56e-06	0.000267	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.53e-06	0.000262	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.53e-06	0.000261	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.51e-06	0.000259	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.51e-06	0.000258	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.38e-06	0.000236	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.37e-06	0.000234	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.36e-06	0.000232	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.33e-06	0.000227	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.3e-06	0.000223	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.29e-06	0.000221	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.28e-06	0.000219	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.25e-06	0.000214	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.19e-06	0.000205	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.19e-06	0.000204	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.16e-06	0.000198	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.14e-06	0.000196	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.14e-06	0.000196	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.06e-06	0.000182	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-06	0.000179	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.04e-06	0.000179	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.01e-07	0.000137	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.39e-07	0.000127	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.25e-07	8.99e-05	CbGpPWpGaD
